Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding.

Insulin-like growth factors IGF-I and IGF -II are important mediators of growth. A family of six high affinity IGF binding proteins (IGFBPs) modulate IGF action. IGFBPs have three domains, of which the N- and C-domains are involved in high affinity IGF binding. IGFBP-6 is unique in its 20-100-fold IGF-II binding specificity over IGF-I. The aim of this study was to determine the contributions of the N- and C-domains of IGFBP-6 to its IGF binding properties. We confirmed that differential dissociation kinetics are responsible for the IGF-II binding preference of IGFBP-6. The N-domain has rapid association kinetics, similar to full-length IGFBP-6, but both IGF-I and -II dissociate rapidly from this domain, thereby reducing its binding affinity for IGF-II approximately 50-fold. However, the N-domain binds IGF-I and -II with similar affinities and it has a similar IGF-I binding affinity to full-length IGFBP-6. This suggests that the C-domain confers the IGF-II binding preference of IGFBP-6; indeed, IGF-I bound inconsistently with very low affinity to the C-domain. Coincubation studies showed that isolated N- and C-domains of IGFBP-6 do not strongly cooperate to enhance IGF binding. The results of the binding studies are supported by the effects of the IGFBP-6 domains on IGF-induced colon cancer cell proliferation; the N-domain inhibited IGF-II induced proliferation with approximately 20-fold lower potency than IGFBP-6 and it was equipotent in inhibiting IGF-I- and IGF-II-induced proliferation. Coincubation of C-domain had no additional effect on N-domain-induced inhibition of proliferation. In conclusion, both the N- and C-domains of IGFBP-6 are involved in IGF binding, the C-domain is responsible for the IGF-II binding preference of IGFBP-6 and intact IGFBP-6 is necessary for high affinity IGF binding.

[1]  S. Chernausek,et al.  Glucocorticoid regulation of an insulin-like growth factor-binding protein-4 protease produced by a rat neuronal cell line. , 1994, Endocrinology.

[2]  M. Rechler,et al.  Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6. , 1993, The Journal of biological chemistry.

[3]  R. Baxter,et al.  Cellular actions of the insulin-like growth factor binding proteins. , 2002, Endocrine reviews.

[4]  P. Grellier,et al.  Expression of insulin-like growth factor-binding protein 6 complementary DNA alters neuroblastoma cell growth. , 1998, Cancer research.

[5]  R. Whitehead,et al.  Insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced but not basal proliferation and adhesion of LIM 1215 colon cancer cells , 2001, Molecular and Cellular Endocrinology.

[6]  A. Scott,et al.  Overexpression of insulin‐like growth factor binding protein‐6 inhibits rhabdomyosarcoma growth in vivo , 2001, International journal of cancer.

[7]  M. Binoux,et al.  A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. , 1996, Endocrinology.

[8]  R. Baxter,et al.  Amino- and carboxyl-terminal fragments of insulin-like growth factor (IGF) binding protein-3 cooperate to bind IGFs with high affinity and inhibit IGF receptor interactions. , 2003, Endocrinology.

[9]  A. Balland,et al.  Isolation from human cerebrospinal fluid of a new insulin‐like growth factor‐binding protein with a selective affinity for IGF‐II , 1989, FEBS letters.

[10]  J. Wallace,et al.  BIAcore Analysis of Bovine Insulin-like Growth Factor (IGF)-binding Protein-2 Identifies Major IGF Binding Site Determinants in Both the Amino- and Carboxyl-terminal Domains* , 2001, The Journal of Biological Chemistry.

[11]  T. Holak,et al.  The interaction of insulin‐like growth factor‐I with the N‐terminal domain of IGFBP‐5 , 2001, The EMBO journal.

[12]  C. Renner,et al.  Structure of the IGF‐binding domain of the insulin‐like growth factor‐binding protein‐5 (IGFBP‐5): implications for IGF and IGF‐I receptor interactions , 1998, The EMBO journal.

[13]  Peter Vorwerk,et al.  Binding properties of insulin-like growth factor binding protein-3 (IGFBP-3), IGFBP-3 N- and C-terminal fragments, and structurally related proteins mac25 and connective tissue growth factor measured using a biosensor. , 2002, Endocrinology.

[14]  M. Rechler,et al.  Isolation of a biologically active fragment from the carboxy terminus of the fetal rat binding protein for insulin-like growth factors. , 1988, Biochemical and biophysical research communications.

[15]  P. Hogarth,et al.  Differential dissociation kinetics explain the binding preference of insulin‐like growth factor binding protein‐6 for insulin‐like growth factor‐II over insulin‐like growth factor‐I , 1999, FEBS letters.

[16]  L. Bach,et al.  The insulin-like growth factor system: basic and clinical aspects. , 1999, Australian and New Zealand journal of medicine.

[18]  M. Yoshida,et al.  Binding Sites and Binding Properties of Binary and Ternary Complexes of Insulin-like Growth Factor-II (IGF-II), IGF-binding Protein-3, and Acid-labile Subunit* , 1997, The Journal of Biological Chemistry.

[19]  R. Norton,et al.  C-terminal domain of insulin-like growth factor (IGF) binding protein-6: structure and interaction with IGF-II. , 2004, Molecular endocrinology.

[20]  D. Clemmons,et al.  Substitutions for Hydrophobic Amino Acids in the N-terminal Domains of IGFBP-3 and -5 Markedly Reduce IGF-I Binding and Alter Their Biologic Actions* , 2000, The Journal of Biological Chemistry.

[21]  J. Wallace,et al.  Localization of an Insulin-like Growth Factor (IGF) Binding Site of Bovine IGF Binding Protein-2 Using Disulfide Mapping and Deletion Mutation Analysis of the C-terminal Domain* , 1998, The Journal of Biological Chemistry.

[22]  R. Norton,et al.  Binding site for the C‐domain of insulin‐like growth factor (IGF) binding protein‐6 on IGF‐II; implications for inhibition of IGF actions , 2004, FEBS letters.

[23]  L. Bach,et al.  The N-terminal Disulfide Linkages of Human Insulin-like Growth Factor-binding Protein-6 (hIGFBP-6) and hIGFBP-1 Are Different as Determined by Mass Spectrometry* , 1999, The Journal of Biological Chemistry.

[24]  J. Terwilliger,et al.  Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. , 2001, Developmental biology.

[25]  D. Andress,et al.  Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells. , 1993, Biochemical and biophysical research communications.

[26]  R. Baxter,et al.  Structural Determinants of Ligand and Cell Surface Binding of Insulin-like Growth Factor-binding Protein-3* , 1998, The Journal of Biological Chemistry.

[27]  R. Baxter,et al.  A central domain binding site in insulin-like growth factor binding protein-5 for the acid-labile subunit. , 2000, Endocrinology.

[28]  J. Fowlkes,et al.  Insulin-like growth factor binding protein proteolysis , 1997, Trends in Endocrinology & Metabolism.

[29]  M. Rechler.  Insulin-like growth factor binding proteins. , 1993, Vitamins and hormones.

[30]  S. Mohan,et al.  Structure-Function Analysis of the Human Insulin-like Growth Factor Binding Protein-4* , 1998, The Journal of Biological Chemistry.

[31]  L. Bach.  Insulin-Like Growth Factor Binding Protein-6: The “Forgotten” Binding Protein? , 1999, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[32]  R. Baxter,et al.  Ligand-binding characteristics of recombinant amino- and carboxyl-terminal fragments of human insulin-like growth factor-binding protein-3. , 2001, The Journal of endocrinology.

[33]  D. Clemmons,et al.  Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.

[34]  J. Beattie,et al.  Amino acids within the extracellular matrix (ECM) binding region (201-218) of rat insulin-like growth factor binding protein (IGFBP)-5 are important determinants in binding IGF-I. , 1999, Journal of molecular endocrinology.

[35]  R. Baxter,et al.  Characterization of truncated insulin-like growth factor-binding protein-2 in human milk. , 1997, Endocrinology.